Engineering of plasminogen activators for targeting to thrombus and heightening thrombolytic efficacy
Early postoperative bridging anticoagulation after mechanical heart valve replacement: a systematic review and meta-analysis
Hypercoagulability and the risk of myocardial infarction and ischemic stroke in young women
Impact of the sharp changes in the use of contraception in 2013 on the risk of pulmonary embolism in France
Prophylaxis in patients with von Willebrand disease: who, when, how?
Prophylaxis escalation in severe von Willebrand disease: a prospective study from the von Willebrand Disease Prophylaxis Network
Clinical impact and course of major bleeding with rivaroxaban and vitamin K antagonists
Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings
Efficacy and safety of edoxaban for treatment of venous thromboembolism: a subanalysis of East Asian patients in the Hokusai-VTE trial
UNBLOCK: an open-label, dose-finding, pharmacokinetic and safety study of bivalirudin in children with deep vein thrombosis
Diagnostic performance of magnetic resonance imaging for acute pulmonary embolism: a systematic review and meta-analysis
Preconception venous thromboembolism and placenta-mediated pregnancy complications
The risk of a first and a recurrent venous thrombosis associated with an elevated D-dimer level and an elevated thrombin potential: results of the THE-VTE study
Laboratory evidence of disseminated intravascular coagulation is associated with a fatal outcome in children with cerebral malaria despite an absence of clinically evident thrombosis or bleeding
Vitamin K antagonists' use and fracture risk: results from a systematic review and meta-analysis
Procoagulant and proinflammatory effects of red blood cells on lipopolysaccharide-stimulated monocytes
Alternatively spliced tissue factor synergizes with the estrogen receptor pathway in promoting breast cancer progression
Correction of human hemophilia A whole blood abnormalities with a novel bypass agent: zymogen-like FXaI16L
Pathological von Willebrand factor fibers resist tissue plasminogen activator and ADAMTS13 while promoting the contact pathway and shear-induced platelet activation
The role of platelet MyD88 in host response during gram-negative sepsis
Targeting of type I protein kinase A to lipid rafts is required for platelet inhibition by the 3′,5′-cyclic adenosine monophosphate-signaling pathway
Challenges in implementation of ISTH diagnostic algorithm for diagnosis and classification of factor XIII deficiency in Iran
Tissue factor expressed by circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in mice: comment
Join the ISTH, the Leading Global Community of Specialists in Thrombosis and Hemostasis